Two Sigma Securities, LLC Mereo Biopharma Group PLC Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.58 - $4.25 $35,929 - $59,185
13,926 New
13,926 $50,000
Q3 2022

Nov 14, 2022
SELL
$0.82 - $1.73 $70,329 - $148,378
-85,768 Reduced 89.52%
10,043 $9,000
Q2 2022

Aug 15, 2022
BUY
$0.33 - $1.69 $26,997 - $138,260
81,811 Added 584.36%
95,811 $107,000
Q1 2022

May 16, 2022
SELL
$1.04 - $1.7 $4,054 - $6,628
-3,899 Reduced 21.78%
14,000 $16,000
Q4 2021

Feb 14, 2022
BUY
$1.51 - $2.59 $27,027 - $46,358
17,899 New
17,899 $29,000

Others Institutions Holding MREO

# of Institutions
86
Shares Held
107M
Call Options Held
209K
Put Options Held
479K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $376M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email